EZAccess Pro turns fragmented payer, HTA and pricing reality into one decisive picture — quantifying profitability, recovering net-sales leakage and ranking the markets where your launch will actually succeed.
Trusted decision logic for global pharmaceutical market access teams.
Market access is decided across dozens of disconnected models, spreadsheets and payer nuances. EZAccess Pro unifies them into a single relational engine — pricing, access, value, profitability and launch sequencing — so every stakeholder works from the same, provenance-backed truth.
Billions ride on getting access, price and market sequencing right. EZAccess Pro replaces fragmented guesswork with a single, defensible decision engine.
Access friction and gross-to-net leakage quietly erode launch value. EZAccess Pro quantifies every point of loss and ranks the highest-ROI actions to recover it — before the money is gone.
Every number is traceable to its source and assumptions. Country-specific regulatory, HTA and reimbursement logic replaces guesswork with a defensible, board-ready rationale.
Sequence markets by realized profitability and time-to-access. Focus scarce launch capital where access is winnable and the return is real.
Import your portfolio of past launches and let realized access, pricing and uptake outcomes drive smarter recommendations for the next one.
Each module is powerful alone — and compounding when connected.
Gross-to-net revenue waterfall with recoverable-opportunity ranking.
Country-level effective access modeling across payer & HTA pathways.
Value & willingness-to-pay evidence tuned to each market.
Net price, erosion and reference-pricing risk over the launch horizon.
Optimal sequencing of markets by profitability and time-to-access.
Side-by-side what-if comparisons on price, access and uptake.
Rebate & value-based deal simulation with ROI and break-even.
Pre-launch checklist, revenue-at-risk and analog-launch matching.
Book a live demo, a strategy conversation, or a working session with our team. We’ll walk your product, indication and target markets through the platform.